Royal Bank of Canada’s Antares Pharma, Inc. ATRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-43,856
Closed -$179K 7610
2022
Q1
$179K Sell
43,856
-25,590
-37% -$104K ﹤0.01% 4711
2021
Q4
$248K Buy
69,446
+25,913
+60% +$92.5K ﹤0.01% 4605
2021
Q3
$159K Buy
43,533
+2,754
+7% +$10.1K ﹤0.01% 4866
2021
Q2
$178K Buy
40,779
+266
+0.7% +$1.16K ﹤0.01% 4703
2021
Q1
$166K Buy
40,513
+3,210
+9% +$13.2K ﹤0.01% 4619
2020
Q4
$149K Buy
37,303
+3,703
+11% +$14.8K ﹤0.01% 4546
2020
Q3
$90K Buy
33,600
+19,187
+133% +$51.4K ﹤0.01% 4562
2020
Q2
$40K Sell
14,413
-22,837
-61% -$63.4K ﹤0.01% 4854
2020
Q1
$88K Buy
37,250
+24,201
+185% +$57.2K ﹤0.01% 4364
2019
Q4
$61K Sell
13,049
-1,201
-8% -$5.61K ﹤0.01% 4767
2019
Q3
$47K Hold
14,250
﹤0.01% 4561
2019
Q2
$47K Sell
14,250
-1,500
-10% -$4.95K ﹤0.01% 4630
2019
Q1
$48K Hold
15,750
﹤0.01% 4520
2018
Q4
$43K Sell
15,750
-4,076
-21% -$11.1K ﹤0.01% 4508
2018
Q3
$66K Buy
19,826
+5,944
+43% +$19.8K ﹤0.01% 4497
2018
Q2
$36K Buy
13,882
+86
+0.6% +$223 ﹤0.01% 4717
2018
Q1
$30K Sell
13,796
-2,776
-17% -$6.04K ﹤0.01% 4699
2017
Q4
$33K Sell
16,572
-5,852
-26% -$11.7K ﹤0.01% 4631
2017
Q3
$73K Buy
22,424
+12,674
+130% +$41.3K ﹤0.01% 4490
2017
Q2
$32K Sell
9,750
-38
-0.4% -$125 ﹤0.01% 4601
2017
Q1
$28K Buy
9,788
+38
+0.4% +$109 ﹤0.01% 4789
2016
Q4
$23K Sell
9,750
-44
-0.4% -$104 ﹤0.01% 4945
2016
Q3
$16K Sell
9,794
-556
-5% -$908 ﹤0.01% 4873
2016
Q2
$10K Hold
10,350
﹤0.01% 5038
2016
Q1
$9K Sell
10,350
-20,073
-66% -$17.5K ﹤0.01% 5070
2015
Q4
$36K Buy
30,423
+12,903
+74% +$15.3K ﹤0.01% 4734
2015
Q3
$29K Sell
17,520
-874
-5% -$1.45K ﹤0.01% 4827
2015
Q2
$39K Buy
18,394
+9,544
+108% +$20.2K ﹤0.01% 4879
2015
Q1
$24K Hold
8,850
﹤0.01% 4833
2014
Q4
$23K Buy
8,850
+1,000
+13% +$2.6K ﹤0.01% 4783
2014
Q3
$15K Buy
7,850
+3,600
+85% +$6.88K ﹤0.01% 4815
2014
Q2
$11K Hold
4,250
﹤0.01% 4877
2014
Q1
$15K Sell
4,250
-1,000
-19% -$3.53K ﹤0.01% 4760
2013
Q4
$23K Sell
5,250
-3,277
-38% -$14.4K ﹤0.01% 4583
2013
Q3
$34K Buy
8,527
+3,277
+62% +$13.1K ﹤0.01% 4412
2013
Q2
$22K Buy
+5,250
New +$22K ﹤0.01% 4402